The conference's organizer, Stephen Spielberg, MD, PhD, Director of the Children's Mercy Center for Personalized Medicine and Therapeutic Innovation; Marion Merrell Dow Chair in Pediatric Pharmacogenomics; and Professor of Pediatrics, University of Missouri- Kansas City School of Medicine, stated that personalized medicine utilizes the latest developments in genomics and molecular data so that they can give the correct medication to the correct patient, in the correct dosage, and at the correct time.
He added that right now, a lot of medications work just for about 50% of the patients who take them, thus, personalized medicine shows high potential to transform the way in which they treat diseases.
During the conference, different experts from academia, government, and the private sector in the US, Canada, and Japan shared their knowledge of clinical applications, bioethics, and the development of pediatric personalized medicine programs.
Some of the clinical applications that were discussed are from the research programs being run at the Children's Mercy, which tackle significant patient challenges like:Applying genomic strategies to improve the safety and efficiency of medications employed to treat cancer in children.
http://www.binaryforexacademy.org/acca-tipster-review/
http://organicsupplementreview.com/curcu-pure-3-review/
http://organicsupplementreview.com/hearing-sense-recovery-review/
Improving the effectiveness and benefit/risk percentage of a common therapeutic agent in treating Juvenile Idiopathic Arthritis, where inter-patient inconsistency causes 40% of the patients to fail to see results.